| Dr Ololade Oluwatoyin Oladimeji, MD | |
|
2615 Chester Ave, Bakersfield, CA 93301-2014 | |
| (661) 395-3000 | |
| Not Available |
| Full Name | Dr Ololade Oluwatoyin Oladimeji |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 19 Years |
| Location | 2615 Chester Ave, Bakersfield, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295179141 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | A139596 (California) | Secondary |
| 208M00000X | Hospitalist | A139596 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Bakersfield | Bakersfield, CA | Hospital |
| Adventist Health Delano | Delano, CA | Hospital |
| Ridgecrest Regional Hospital | Ridgecrest, CA | Hospital |
| Adventist Health Tehachapi Valley | Tehachapi, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospitalist Medicine Physicians Of California Inc | 8426062027 | 178 |
News Archive
The complication/failure and morbidity rates of laparoscopic Roux-en-Y gastric bypass can be substantially reduced by the routine use of intraoperative endoscopy with the linear anastomosis technique, the results of a US study indicate.
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.
Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of California Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184663965 PECOS PAC ID: 8426062027 Enrollment ID: O20060202000956 |
News Archive
The complication/failure and morbidity rates of laparoscopic Roux-en-Y gastric bypass can be substantially reduced by the routine use of intraoperative endoscopy with the linear anastomosis technique, the results of a US study indicate.
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.
Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
› Verified 2 days ago
| Entity Name | Kansal Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043510183 PECOS PAC ID: 6406089739 Enrollment ID: O20140512001295 |
News Archive
The complication/failure and morbidity rates of laparoscopic Roux-en-Y gastric bypass can be substantially reduced by the routine use of intraoperative endoscopy with the linear anastomosis technique, the results of a US study indicate.
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.
Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
› Verified 2 days ago
| Entity Name | Inpatient Specialists Of California Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952792475 PECOS PAC ID: 3476864448 Enrollment ID: O20150617000915 |
News Archive
The complication/failure and morbidity rates of laparoscopic Roux-en-Y gastric bypass can be substantially reduced by the routine use of intraoperative endoscopy with the linear anastomosis technique, the results of a US study indicate.
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.
Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
› Verified 2 days ago
| Entity Name | Hospitalist Medicine Physicians Of California - Oceanside |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033697669 PECOS PAC ID: 5597002139 Enrollment ID: O20190121001542 |
News Archive
The complication/failure and morbidity rates of laparoscopic Roux-en-Y gastric bypass can be substantially reduced by the routine use of intraoperative endoscopy with the linear anastomosis technique, the results of a US study indicate.
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.
Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ololade Oluwatoyin Oladimeji, MD 2615 Chester Ave, Bakersfield, CA 93301-2014 Ph: (661) 395-3000 | Dr Ololade Oluwatoyin Oladimeji, MD 2615 Chester Ave, Bakersfield, CA 93301-2014 Ph: (661) 395-3000 |
News Archive
The complication/failure and morbidity rates of laparoscopic Roux-en-Y gastric bypass can be substantially reduced by the routine use of intraoperative endoscopy with the linear anastomosis technique, the results of a US study indicate.
"Ahead of World Cancer Day, the United Nations health agency Friday launched a survey showing that more than half of all countries are struggling to prevent cancer and to provide appropriate long-term treatment and care to avoid human suffering and protect countries' social and economic development," the U.N. News Centre reports.
Nuon Therapeutics, Inc., a privately held, clinical stage biopharmaceutical company, announced that results from clinical and preclinical studies demonstrating the ability of tranilast to reduce serum uric acid levels and monosodium urate crystal-induced inflammation - two important risk factors for gout - were presented at The European League Against Rheumatism (EULAR) 2010 Annual European Congress of Rheumatology in Rome, Italy, June 16-19, 2010.
A sweeping new report assessing chronic kidney disease in the United States offers startling statistics about a condition that affects almost 14 percent of the U.S. population and costs billions in Medicare spending each year.
Ipsen announced today that the Committee for Medicinal Products for Human Use, the scientific committee of the European Medicines Agency, provided a positive opinion for Cabometyx (cabozantinib) as a monotherapy for the treatment of hepatocellular carcinoma in adults who have been previously treated with sorafenib.
› Verified 2 days ago
Ritam Sidhu, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9500 Stockdale Hwy Ste 203, Bakersfield, CA 93311 Phone: 661-587-8110 Fax: 661-587-8220 | |
Mohammed Siddiqui, M.B.B.S Hospitalist Medicare: Medicare Enrolled Practice Location: 4580 California Ave, Bakersfield, CA 93309 Phone: 661-327-4411 | |
Dr. Jeffrey Andrew Coleman, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9500 Stockdale Hwy Ste 203, Bakersfield, CA 93311 Phone: 661-587-8110 Fax: 661-587-8220 | |
Ravi K Solanki, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 6512 Norris Rd Unit B, Bakersfield, CA 93308 Phone: 661-428-5283 | |
Harsukh Nidhan Singh Dhillon, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9500 Stockdale Hwy Ste 203, Bakersfield, CA 93311 Phone: 661-587-8110 Fax: 661-587-8220 | |
Chirag M Mathukia, Hospitalist Medicare: Medicare Enrolled Practice Location: 5055 California Ave, Suite 300, Bakersfield, CA 93309 Phone: 661-334-2016 | |
Dr. Nosheen Hasan, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 9500 Stockdale Hwy Ste 203, Bakersfield, CA 93311 Phone: 661-587-8110 Fax: 661-587-8220 |